A number of sessions on the second day of IPWatchdog LIVE examined the state of U.S. IP policy and the potential for change ...
California made a big bet on producing its own insulin. There’s no ‘date certain’ for delivery
Gov. Gavin Newsom has yet to make good on his promise of state-produced, affordable insulin for diabetics. What's the hold up ...
LEQEMBI (lecanemab) has significant market potential due to the high global prevalence of the condition and the demand for disease-modifying treatmen ...
The stagflation specter is spooking traders today, wiping out the risk-on move that was buoying stocks and weighing on board ...
One of the worst flu seasons in years has reached its peak and is improving, officials with the Centers for Disease Control ...
Secretary, Measles-dismisser, nepo-baby, bear cub-dumper, and vaccine skeptic, Robert F. Kennedy, Jr., was one of the ...
Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the ...
Verve Therapeutics remains a high-reward investment despite setbacks. Click here to find out why VERV stock is a Buy.
Eli Lilly is making a massive $50 billion investment in U.S. manufacturing. This move more than doubles their previous $23 ...
Eli Lilly and Company, Hims & Hers Health, UnitedHealth Group, Walmart, Tempus AI, Johnson & Johnson, and Merck & Co., Inc. are the seven Medical stocks to watch today, according to MarketBeat’s stock ...
At the four new sites, Lilly expects to create more than 3,000 jobs for engineers, scientists, operations personnel, and lab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback